Harm Reduction Journal

Article	Citations
The underbelly of E-cigarette advertising: regulating online markets on social media platforms	90
Social and environmental determinants influencing injection drug use and HIV risk among two sister cities on the US–Mexico border: a comparative cross-sectional study, 2016–2018	83
Community-based respondent-driven sampling as a strategy for drug use surveillance in a large French urban area	59
Accessing needle exchange services in disasters for remote areas of Aotearoa New Zealand	47
Municipal police support for harm reduction services in officer-led referrals of people who inject drugs in Tijuana, Mexico	47
How a sample of English stop smoking services and vape shops adapted during the early COVID-19 pandemic: a mixed-methods cross-sectional survey	46
How post overdose response efforts can address social determinants of health among people who use drugs: perspectives from the New York State Department of Health (NYSDOH) Post Overdose Response Team	45
Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment	41
The acceptability of overdose alert and response technologies: introducing the TPOM-ODART framework	41
Interim opioid agonist treatment for opioid addiction: a systematic review	40
Assessing experts’ perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State	40
The hazardous (mis)perception of Self-estimated Alcohol intoxication and Fitness to drivE—an avoidable health risk: the SAFE randomised trial	38
High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatment	37
Acceptability of a pilot motivational interviewing intervention at public health facilities to improve the HIV treatment cascade among people who inject drugs in Indonesia	35
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021	34
Acceptability of supervised injection facilities among persons who inject drugs in upstate New York	33
The generative potential of mess in community-based participatory research with young people who use(d) drugs in Vancouver	33
Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA	33
Association between heaviness of cigarette smoking and serious psychological distress is stronger in women than in men: a nationally representative cross-sectional survey in Japan	32
The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in a rural American state	32
Subspecialty physicians’ perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study	29
Does sexuality matter? A cross-sectional study of drug use, social injecting, and access to injection-specific care among men who inject drugs in Melbourne, Australia	29
“I don’t want to die”: a qualitative study of coping strategies to prevent fentanyl-related overdose deaths among people who inject drugs and its implications for harm reduction policies	28
Egocentric network characteristics of people who inject drugs in the Chicago metro area and associations with hepatitis C virus and injection risk behavior	26
Contamination of a drug consumption room with drugs and potential risks for social health care workers	26

Patterns of cannabis use, perception of harm, and perceived impact of legislative change in an online sample of young adults from Lebanon: insight on recreational users versus dual motive users	25
Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study	24
A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City	23
Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation	23
Motives for alcohol use, risky drinking patterns and harm reduction practices among people who experience homelessness and alcohol dependence in Montreal	23
A Case report of a continuous ambulatory drug delivery (CADD) pump to deliver opioid agonist treatment in an acute care setting	23
Double counting of clients using services in Iran: implications for assessing the reach of harm reduction programs	23
A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa	22
“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises	22
Exploring substance use disorder discussions in Native American communities: a retrospective Twitter infodemiology study	22
Xylazine awareness and attitudes among people who use drugs in Ohio, 2023–2024	21
“It’s starting to weigh on me”: Exploring the Experiences and Support Needs of Harm Reduction Staff in Connecticut using the Social-Ecological Model	21
Decentralised same day test and treatment of hepatitis C levering existing peer support networks among men who inject drugs: feasibility and effectiveness	20
The impact of JUUL market entry on cigarette sales: evidence from a major chain retailer in Canada	19
Awareness and willingness to use HIV self-testing among people who inject drugs in Iran	19
Is peer support a tipping point for the opioid use disorder crisis in Appalachia? Research holds the answer	19
HIV prevalence and continuum of care among incarcerated people in Iran from 2010 to 2017	18
Perceptions, intentions, and actual use of a consumer nicotine gum	18
A step change model analysis of the establishment of pill testing in one Australian jurisdiction	18
Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego–Tijuana border region	17
Physiologic oxygen responses to smoking opioids: an observational study using continuous pulse oximetry at overdose prevention services in British Columbia, Canada	17
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study	17
An exploratory, randomised, crossover study to investigate the effect of nicotine on cognitive function in healthy adult smokers who use an electronic cigarette after a period of smoking abstinence	17
The potential of new nicotine and tobacco products as tools for people who smoke to quit combustible cigarettes – a systematic review of common practices and guidance towards a robust study protocol t	17
Managed alcohol: one community’s innovative response to risk management during COVID-19	16
The quality of health information provided on web sites selling cannabis to consumers in Canada is poor	16
Prevalence and correlates of using opioids alone among individuals in a residential treatment program in Michigan: implications for overdose mortality prevention	16
Reporting and methodological quality of systematic literature reviews evaluating the associations between e-cigarette use and cigarette smoking behaviors: a systematic quality review	16
Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia	16
Treatment non-adherence among methadone maintenance patients and associated factors: a multicenter, cross-sectional study in Vietnam	16
Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review	16
“Just another thing for me to stress off of”: Responses to unintentional fentanyl use in a community-based study of people who use opioids	16
Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019–April 2020	16
The relationship between felt stigma and non-fatal overdose among rural people who use drugs	15
Examining common mental health disorders in people living with HIV on methadone maintenance therapy in Hanoi, Vietnam	15
Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian ‘surveillance and treatment of prisoners with hepatitis C’ proje	15
Developing an ethical framework for the recruitment of people who inject drugs experiencing incarceration in HIV prevention research: a qualitative study	14
Relational anonymity in reducing the harms of illicit drug use: accounts of users of dark web- and street-based services in Finland	14
Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?	14
Understanding the financial barriers to treatment among individuals with opioid use disorder: a focus group study	14
Exploring perceived quality of life in long-term methadone-dependent patients: a qualitative study	14
Harm reduction and its monitoring in Europe, from EMCDDA to EUDA	14
“We were building the plane as we were flying it, and we somehow made it to the other end”: syringe service program staff experiences and well-being during the COVID-19 pandemic	14
Practical solutions to resolve social barriers to hepatitis C treatment initiation among people who inject drugs: a qualitative study	14
Decentralized HIV testing: comparing peer and mail-based distribution strategies to improve the reach of HIV self-testing among people who use drugs in Florida	13
HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA	13
Decolonizing drug policy	13
The challenges, opportunities and strategies of engaging young people who use drugs in harm reduction: insights from young people with lived and living experience	13
Understanding Vietnam’s drug policy for amphetamine-type stimulants misuse	13
Moving from ‘stigma reduction’ to ‘inclusion’: development of the inclusion collaborative at Nepean Blue Mountains Local Health District, New South Wales	13

NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users	13
Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies	13
Opioid-specific harm reduction in the emergency department: how staff provide harm reduction and contextual factors that impact their capacity to engage in harm reduction practice	13
Stigma and level of familiarity with opioid maintenance treatment (OMT) among specialist physicians in Israel	12
“Wanna cry this out real quick?”: an examination of secondary traumatic stress risk and resilience among post-overdose outreach staff in Massachusetts	12
The effect of different types of migration on symptoms of anxiety or depression and experience of violence among people who use or inject drugs in Kachin State, Myanmar	12
A qualitative investigation exploring why dance festivals are risky environments for drug use and potential adverse outcomes	12
Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals “blind spots” in detection capabilities	12
Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: a qualitative study	12
Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage	12
Experiences of harm and mental ill-health among gay, bisexual and other men-who-have-sex-with-men who use methamphetamine or GHB/GBL in different combinations: findings from the COMeT study in Taiwan	12
Identifying barriers to hepatitis B and delta screening, prevention, and linkage to care among people who use drugs in Philadelphia, Pennsylvania, USA	12
Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs	11
Decolonizing harm reduction	11
Expanding single-venue services to better engage young people who inject drugs: insights from India	11
Identifying the facilitators of Iran’s alcoholic beverage black market and presenting solutions for harm reduction: a qualitative document analysis	11
Perspectives on long-acting injectable HIV antiretroviral therapy at an alternative care site: a qualitative study of people with HIV experiencing substance use and/or housing instability	11
A universal precautions approach to reducing stigma in health care: getting beyond HIV-specific stigma	10
Is smokeless tobacco a healthier option in patients with AUD? A follow-up study during treatment	10
Responding to a surge in overdose deaths: perspectives from US syringe services programs	10
The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study	10
Different phases of ATS use call for different interventions: a large qualitative study in Europe	10
The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19	10
Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking	10
“They're causing more harm than good”: a qualitative study exploring racism in harm reduction through the experiences of racialized people who use drugs	10
Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?	10
People Who Inject Drugs in Mozambique: We need to normalize HIV treatment and care services in specialized community centers for people who inject drugs!	10
“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs	10
Peer support workers as a bridge: a qualitative study exploring the role of peer support workers in the care of people who use drugs during and after hospitalization	10
Implementation and first-year operating costs of an academic medical center-based syringe services program	10
Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City	10
Attitudes towards people who use substances: a survey of mental health clinicians from an urban hospital in British Columbia	10
Is expected substance type associated with timing of drug checking service utilization?: A cross-sectional study	10
The motives and methods of methamphetamine and ‘heroin’ co-use in West Virginia	10
The “Gateway” hypothesis: evaluation of evidence and alternative explanations	10
Factors associated with receptive injection equipment sharing among people who inject drugs: findings from a multistate study at the start of the COVID-19 pandemic	9
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report	9
Supporting syringe services programs in the initiation and scale-up of vaccine administration: findings from in-depth interviews	9
Correction: ‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts	9
People who use drugs and the right to health	9
Correction: Co‑designing drug alerts for health and community workers for an emerging early warning system in Victoria, Australia	9
Respiratory health effects of e-cigarette substitution for tobacco cigarettes: a systematic review	9
Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study	9
“It is the One Thing that has Worked”: facilitators and barriers to switching to nicotine salt pod system e-cigarettes among African American and Latinx people who smoke: a content analysis	9
Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative	9
Health workers’ perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia	9
Correction: Using digital technology to reduce drug-related harms: a targeted service users’ perspective of the Digital Lifelines Scotland programme	9
Correction: Health workers’ perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia	9
Opioid-related harms and experiences of care among people in justice settings in New South Wales, Australia: evidence from the National Ambulance Surveillance System	9
Adherence to opioid agonist therapy predicts uptake of direct-acting antivirals in people who use drugs: results from the French national healthcare database (the ANRS FANTASIO study)	9
Challenges for the implementation of injectable opioid agonist treatment: a scoping review	9
The fentanyl made me feel like I needed more methadone”: changes in the role and use of medication for opioid use disorder (MOUD) due to fentanyl	9
‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts	9
Co-designing drug alerts for health and community workers for an emerging early warning system in Victoria, Australia	9
Correction to: An exploratory non-randomized study of a 3-month electronic nicotine delivery system (ENDS) intervention with people accessing a homeless supported temporary accommodation service (STA)	9
Door-to-door overdose harm reduction: an Illinois case study	9
Mind the G(ap): bridging prevention needs and approaches for GHB/GBL users and their social environment	9
“The new normal has become a nonstop crisis”: a qualitative study of burnout among Philadelphia’s harm reduction and substance use disorder treatment workers during the COVID-19 pandemic	8
The high frequency of alcohol advertising during televised English Premier League football games shown in Ethiopia	8
Differential risks of syringe service program participants in Central Ohio: a latent class analysis	8
Sexualized drug injection among men who have sex with men in Madrid and Barcelona as the first episode of drug injecting	8
Shock and awe or incentive-compatible harm reduction? Graphic health warnings on tobacco packages	8
When it comes to assessing the impact of e-cigarettes, estimates of device prevalence matter: the BIDI Stick disposable device	8
SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya	8
“There’s absolutely no downside to this, I mean, except community opposition:” A qualitative study of the acceptability of vending machines for harm reduction	8
Association of hospital-based substance use supports on emergency department revisits: a retrospective cohort study in Sudbury, Canada from 2018 to 2022	8
“It’s a delicate balance”: clinicians’ experiences of providing heroin-assisted treatment	8
Combining respondent-driven sampling with a community-based participatory action study of people who smoke drugs in two cities in British Columbia, Canada	8
Critical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electronic cigarettes	8
Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma	8
Testing the influence of harm reduction messages on health risk attitudes, injunctive norms and perceived behavioral control	8
Opioid overdose prevention education in Texas during the COVID-19 pandemic	8
The study of feasibility and acceptability of using HIV self-tests in high-risk Iranian populations (FSWs, MSM, and TGs): a cross-sectional study	8
Channelling and taxation in European online gambling markets: evolution and policy implications	8
Online interventions and virtual day centres for young people who use drugs: potential for harm reduction?	8
Implementing harm reduction kits in an office-based addiction treatment program	7
Community-Engaged Research Ethics Training (CERET): developing accessible and relevant research ethics training for community-based participatory research with people with lived and living experience	7
Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis	7
“Naloxone? Not for me!” First cross-assessment by patients and healthcare professionals of the risk of opioid overdose	7
Therapy of chronic hepatitis C in people who inject drugs: focus on adherence	7

“Prevention of opioid use disorder: the HOME (housing, opportunities, motivation and engagement) feasibility study”	7
Older adult drug overdose: an application of latent class analysis to identify prevention opportunities	7
Need for integration of hepatitis C (HCV) services in community-based settings for people who inject drugs: results from a global values and preferences survey	7
Reducing the stigma surrounding opioid use disorder: evaluating an opioid overdose prevention training program applied to a diverse population	7
Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study	7
Psychosocial factors associated with overdose subsequent to Illicit Drug use: a systematic review and narrative synthesis	7
“It’s like a safety net for when things go wrong”: key stakeholder and program user perspectives on a peer-led safe space program in Sydney, Australia	7
‘I’m not going to leave someone to die’: carriage of naloxone by police in Scotland within a public health framework: a qualitative study of acceptability and experiences	7
Harm reduction must be recognised an essential public health intervention during crises	7
The group-based law enforcement mistrust scale: psychometric properties of an adapted scale and implications for public health and harm reduction research	7
The implementation of safer drug consumption facilities in Scotland: a mixed methods needs assessment and feasibility study for the city of Edinburgh	7
Association of spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New England, United States	7
Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications	7
Cannabis donation as a harm reduction strategy: a case study	7
Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic	7
Vaping among Norwegians who smoke or formerly smoked: reasons, patterns of use, and smoking cessation activity	7
“I would rather do it myself”: injection initiation and current injection patterns among women who inject drugs in Tijuana, Mexico	7
The war on drugs is a war on us: young people who use drugs and the fight for harm reduction in the Global South	7
Comparing professional communities: Opioid prescriber networks and Public Health Preparedness Districts	7
Improving hospital care for people who use drugs: deliberative process development of a clinical guideline for opioid withdrawal management	7
Harm reduction social work with people who use drugs: a qualitative interview study with social workers in harm reduction services in Sweden	7
Identifying drivers of increasing opioid overdose deaths among black individuals: a qualitative model drawing on experience of peers and community health workers	7